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Abstract
Background: The airway epithelium participates in asthmatic inflammation in many ways. Target cells of the epithelium can
respond to a variety of inflammatory mediators and cytokines. Damage to the surface epithelium occurs following the
secretion of eosinophil-derived, highly toxic cationic proteins. Moreover, the surface epithelium itself is responsible for the
synthesis and release of cytokines that cause the selective recruitment, retention, and accumulation of various inflammatory
cells. To mimic the damage seen during asthmatic inflammation, the bronchial epithelium can be challenged with highly
charged cationic polypeptides such as poly-L-arginine.
Methodology/Principal Findings: In this study, human bronchial epithelial cells, 16HBE14o- cells, were ‘‘chemically injured’’
by exposing them to poly-L-arginine as a surrogate of the eosinophil cationic protein. Cytokine antibody array data showed
that seven inflammatory mediators were elevated out of the 40 tested, including marked elevation in interleukin (IL)-6 and
IL-8 secretion. IL-6 and IL-8 mRNA expression levels were elevated as measured with real-time PCR. Cell culture supernatants
from apical and basolateral compartments were collected, and the IL-6 and IL-8 production was quantified with ELISA. IL-6
and IL-8 secretion by 16HBE14o- epithelia into the apical compartment was significantly higher than that from the
basolateral compartment. Using specific inhibitors, the production of IL-6 and IL-8 was found to be dependent on p38
MAPK, ERK1/2 MAPK, and NF-kB pathways.
Conclusions/Significance: The results clearly demonstrate that damage to the bronchial epithelia by poly-L-arginine
stimulates polarized IL-6 and IL-8 secretion. This apically directed secretion of cytokines may play an important role in
orchestrating epithelial cell responses to inflammation.
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Introduction
Human airways are lined by a layer of surface epithelium,
which are essential to the integrated function (e.g., effective mucus
clearance) of the respiratory tract in health and disease [1,2].
Asthma is now considered to be an inflammatory disorder of the
airways [3]. Eosinophils are believed to play a more important role
than other inflammatory cells. There is an association between
tissue eosinophilia and the airway hyper-responsiveness of asthma.
The release of pro-inflammatory cytokines such as IL-4 and IL-5
that leads to the recruitment and infiltration of eosinophils is thus a
hallmark of asthma [4]. The eosinophils degranulate, releasing a
range of highly charged molecules (e.g., toxic cationic proteins)
that damage the respiratory epithelium and account for many of
the histopathologic abnormalities of asthma [5].
The airway epithelium participates in inflammation in many
ways. The cells can act as target cells that respond to exposure to a
variety of inflammatory mediators and cytokines by altering one or
several of their functions, such as mucin secretion or ion transport
[6]. Damage to the surface epithelium is due to the secretion of
eosinophil-derived, highly toxic cationic proteins, such as major
basic protein (MBP) [7]. To mimic the damage seen in asthma
inflammation, the bronchial epithelium can be challenged with
highly charged cationic polypeptides such as poly-L-arginine,
which is similar in structure and function to the biologically active
moiety of MBP [8–10]. Moreover, the surface epithelium itself is
responsible for the synthesis and release of cytokines that cause the
selective recruitment, retention, and accumulation of various
inflammatory cells [3]. IL-6 and IL-8 are two classic proin-
flammatory cytokines that play important roles in bronchial
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the fluid and electrolyte transport by the airway epithelium
[13,14]. Therefore, asthma can be considered a disease of the
bronchial epithelium, which may contribute to the pathophysiol-
ogy of airway inflammation [15].
Polarized secretion of proinflammatory cytokines is important
for establishing a specific microenvironment for airway inflam-
mation. However, little is known about the polarized secretion of
proinflammatory cytokines and its underlying signaling pathway in
human bronchial epithelia damaged by cationic proteins. The
aims of this study were to 1) investigate the inflammatory cytokine
profile of human bronchial epithelia 16HBE14o- cells in response
to a challenge with the cationic polypeptide poly-L-arginine; 2)
study the polarized secretion of IL-6 and IL-8; 3) characterize the
role of MAPK and NF-kB signaling pathways in the regulation of
IL-6 and IL-8 secretion; and 4) examine the effect of IL-6 and IL-8
on transepithelial chloride (Cl
2) secretion.
Methods
Cell Culture
All experiments were performed using the immortalized cell line
16HBE14o-, which was derived from bronchial surface epithelial
cells [16]. Cells were maintained in Minimum Essential Medium
as described previously [17]. For cytokine quantification, cells
were seeded onto 24-well Transwell-Clear filter inserts (Costar,
Cambridge, MA) with a 0.4-mm pore diameter. For transepithelial
resistance (TER) measurement and simultaneous measurements of
intracellular calcium concentration ([Ca
2+]i) and short-circuit
current (ISC), cells were seeded onto Transwell-col filter mem-
branes as previously described [18,19]. Cells reached confluence
after 10 days with a resistance greater than 150 V?cm
2. For
quantitative real-time PCR (qRT-PCR) and other experiments,
cells were grown on 6-well culture plates.
RNA extraction and Real-time PCR
Total RNA was extracted with TRIzol Reagent (Invitrogen,
Carlsbad, CA) according to the manufacturer’s instructions as
described previously [17]. After treatment with DNase (Turbo
DNA-free Kit, Ambion, Austin, TX), RNA was reverse tran-
scribed to cDNA using a High Capacity cDNA Reverse
Transcription kit (Applied Biosystems, Foster City, CA). Real-
time PCR was performed with LightCycler 480 SYBR Green I
Master Mix (Roche, Indianapolis, IN) on an iCycler thermal
cycler (Bio-Rad Laboratories, CA). Primer sequences were as
follows: IL-6 forward primer: 59-GCACTGGCAGAAAACA-
ACCT-39, reverse primer: 59-TCAAACTCCAAAAGACCAG-
TGA-39; IL-8 forward primer: 59-CCAACACAGAAATTATTG-
TAAAGC-39, reverse primer: 59-TGAATTCTCAGCCCTCTT-
CAA-39, GAPDH: forward primer: 59-TGCACCACCAAC-
TGCTTAGC-39, reverse primer: 59-GGCATGGACTGTGGT-
CATGAG-39. Relative expression of IL-6 and IL-8 was
normalized to GAPDH and determined with the Pfaffl method
[20]. A standard curve of Ct versus concentration was plotted to
obtain the efficiency of each PCR reaction. This efficiency (E) can
be obtained by the formula 10
–(1/slope), with an acceptable range
1.8–2.2. Each PCR run included a no-template control and a
sample without reverse transcriptase. All measurements were
performed in duplicate.
Measurement of transepithelial resistance (TER)
Confluent 16HBE14o- epithelia were used to measure TER as
described previously [19]. The monolayers were mounted in an
Ussing chamber and bathed in normal Krebs-Henseleit (K–H)
solution. A transepithelial potential difference (p.d.) of 1 mV was
applied periodically, and the resultant change in current was used
to calculate the TER using Ohm’s law. After an equilibrium
period of 30 min, the cultured epithelia were incubated with
10 mM poly-L-arginine for 1–5 hours with untreated epithelia as
control. All TER values were determined after background
subtraction (contributed by the filter and bath solution) and
multiplied by the surface area of the filter.
Measurement of cytokine secretion by antibody array
and enzyme-linked immunosorbent assay (ELISA)
16HBE14o- cells were incubated with 10 mM poly-L-arginine
for 3 hours, and cells incubated with fresh non-serum-containing
medium were used for time-matched controls. Cell culture
supernatants were collected and centrifuged at 30006g for
10 min at 4uC. The supernatants were then aliquotted and stored
at 280uC until further use. The cytokine profile of the cell culture
supernatants was analyzed with a RayBioH Human Inflammatory
Antibody Array III kit according to the manufacturer’s instruc-
tions. The membrane in this kit can simultaneously detect 40
different inflammation-related factors, including cytokines, che-
mokines, soluble cytokine receptors, and growth factors [21,22].
The membranes were detected using chemiluminescence (Amer-
sham Pharmacia Biotech, UK) for 1 min at room temperature.
The membranes were then exposed to Fuji Film (Fuji, Japan) for
2 min. The signal intensity of individual spots was quantified with
the FluorChem
TM 8000 imaging system (Alpha Innotech Corp.) A
positive control signal on each membrane was used to normalize
the signal intensities of individual spots being compared on
different membranes.
Quantification of IL-6, IL-8, TNFa and RANTES secretion
was done with enzyme-linked immunosorbent assay (ELISA).
16HBE14o- cells were exposed to different concentrations of poly-
L-arginine, with or without pharmacological inhibitors, for various
periods of times. Supernatant samples from the apical and
basolateral compartments were collected, and IL-6, IL-8, TNFa
(eBioscience, San Diego, CA) and RANTES (R&D Systems,
Minneapolis, MN) secretion was assessed with commercially
available ELISA kits, according to the manufacturer’s protocol.
All conditions were measured in duplicate.
Western Blot
Western blotting was performed as described previously [17]. In
brief, cells grown in a 6-well plate were lysed in RIPA buffer (1%
NP-40, 0.1% SDS, 0.5% deoxycholic acid, 50 mM Tris-HCl
(pH 7.4), 150 mM NaCl) supplemented with protease inhibitor
cocktail. The protein samples were transferred to a polyvinylidene
fluoride (PVDF) membrane (Immobilon-P, Millipore Corporation,
Billerica, MA) and immunoblotted with specific primary antibody.
All blots were developed by an enhanced chemiluminescence
detection system (Amersham Biosciences, Piscataway, NJ). The
following primary antibodies were used: anti-phospho-p38 MAPK
(Cell Signaling Technology, Beverly, MA; 1:500), anti-p38 MAPK
(Cell Signaling Technology; 1:500), anti-phospho-p44/42 MAPK
(ERK 1/2) (Cell Signaling Technology; 1:500), anti-p44/42
MAPK (ERK 1/2) (Cell Signaling Technology; 1:500), anti-b-
tubulin (Santa Cruz Biotechnology, Santa Cruz, CA; 1:500), and
anti-GAPDH (Sigma, St. Louis, MO; 1:5,000).
NF-kB translocation assay
Cells were grown in black 96-well glass-bottomed plates (Costar)
and stimulated with either vehicle control, 1 mM poly-L-arginine,
or an inflammatory cocktail (10 ng/ml each tumor necrosis factor-
Polarized Cytokine Secretion
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Measurement of translocation of NF-kB from the cytoplasm to the
nucleus was performed using a Cellomics NF-kB Activation Kit
TM
(Thermo Fisher Scientific, Pittsburgh, PA) according to the
manufacturer’s validated protocol as described by others [23,24].
The nucleus was immunostained with Hoechst 33342, and NF-kB
was detected with an NF-kB primary antibody and Alexa Fluor
488–conjugated goat anti-rabbit IgG secondary antibody. Micro-
scopic images were captured with the MetaFluor Imaging System
(v.7.5, Molecular Devices, Downingtown, PA) equipped with a
cooled CCD camera (Quantix, Photometrics, Tucson, AZ). Image
analysis was performed using NIH ImageJ software (v.3.91,
http://rsbweb.nih.gov/ij/) as described by Noursadeghi M. et al.
[25]. NF-kB nuclear translocation is represented as an increase in
the nucleus:cytoplasm ratio.
Simultaneous measurements of [Ca
2+]i and ISC
Agonist-induced calcium signals and anion secretion were
measured simultaneously in polarized epithelium as described
[17–19]. Positive ISC currents are displayed as upward deflections
of the traces and were defined as those carried by anions moving
from the basolateral to apical compartments. The effects of IL-6
and IL-8 on agonist-evoked ISC changes were tested by pre-
incubating the epithelia with the cytokine for 1–3 days prior to
addition of the agonist.
Materials and solutions
The bicarbonate-buffered K-H solution contained (in mM)
NaCl, 117; NaHCO3, 25; KCl, 4.7; MgSO4, 1.2; KH2PO4, 1.2;
CaCl2, 2.5; and D-glucose, 11; pH 7.4 when bubbled with 5%
CO2/95% O2. The low Cl
2 solution (10 mM) was prepared by
isosmotically replacing NaCl, KCl, CaCl2, and MgCl2 with Na-
gluconate, K-gluconate, Ca-gluconate, and Mg-sulphate, respec-
tively. The membrane permeant acetoxymethylester (AM) forms
of Fura-2 and pluronic F127 were obtained from Molecular
Probes (Eugene, OR). Uridine 59-triphosphate (UTP), forskolin,
and poly-L-arginine were obtained from Sigma-Aldrich. The
human cytokine antibody array kit was from RayBiotech Inc.
(Norcross, GA). IL-6 and IL-8 ELISA kits were obtained from
eBioscience (San Diego, CA), and recombinant human IL-6 and
IL-8 were from PeproTech Inc. (Rocky Hill, NJ). All other general
laboratory reagents were obtained from Sigma-Aldrich, and all cell
culture reagents were obtained from Invitrogen.
Data analysis
Pooled data are presented as means 6 standard errors (S.E.),
and values of n refer to the number of experiments in each group.
Experimentally-induced changes (D) in the Fura-2 fluorescence
ratio and ISC were quantified by measuring each parameter at the
peak of a response and subtracting the equivalent values measured
immediately prior to stimulation. Statistical comparisons between
original data before normalization were performed using Student’s
t-test and analysis of variance, where appropriate, with a p,0.05
considered significant.
Results
Effect of poly-L-arginine on TER
TER is an electrical parameter that represents the resistance to
ion flow through both paracellular and transcellular pathways. In
this study, the effect of poly-L-arginine on TER of cultured
16HBE14o- cells was measured. Fig. 1 shows the time course of
the effect of poly-L-arginine on cultured 16HBE14o- cells. The
cultured epithelia were incubated with 10 mM poly-L-arginine for
1–5 hours. Each TER measurement was normalized to the initial
value without poly-L-arginine treatment. The TER decreased in a
time-dependent manner and reached its minimum at 4 hours.
Treating the epithelia for 2–5 hours produced a significant
reduction in TER. The data therefore confirmed the damaging
effect of poly-L-arginine as a surrogate for MBP on TER of the
airway epithelium as seen in eosinophilic inflammation [26].
Poly-L-arginine triggered secretion of cytokines and
chemokines by 16HBE14o- cells
To further understand the effect of poly-L-arginine in
stimulating bronchial epithelial cell cytokine and chemokine
secretion, we first examined the cytokine profile in bronchial
epithelial cells using the membrane-based RayBioH Human
Inflammation Antibody Array III [21,22]. Fig. 2A and 2B show
the control and poly-L-arginine-treated patterns of antibody array
images, respectively. The mean optical density of each spot was
normalized to the positive control and compared between control
and treated epithelia (Fig. 2C). After exposure of the cultured
epithelial cells to 10 mM poly-L-arginine for 3 hours, the intensities
of two inflammation-related factors (IL-8 and RANTES) increased
more than 2-fold, and two other factors (IL-6 and IL-6 soluble
receptor [IL-6sR]) increased 5-fold as compared to the control
(Fig. 2C). Moreover, the intensities of TNF-a, IL-1a, and IL-12
p40 also increased significantly.
Apically directed secretion of IL-6, IL-8, TNFa and RANTES
by polarized 16HBE14o- epithelia
Because epithelia mainly secreted IL-6 and IL-8 into the
supernatant in response to poly-L-arginine treatment, we next
determined the concentrations of IL-6 and IL-8 secreted by the
epithelia. To quantify the polarized secretion of IL-6 and IL-8,
supernatant samples obtained from apical or basolateral compart-
ments were analyzed by ELISA. Fig. 3A and 3B show the time
course of the effect of poly-L-arginine on IL-6 release into apical
and basolateral compartments, respectively. Exposure to 50 mM
apical poly-L-arginine stimulated a time-dependent increase in
Figure 1. TER measurement during poly-L-arginine exposure.
TER was measured at 0, 1, 2, 3, 4, and 5 hours after cells were exposed
to poly-L-arginine (50 mM, ap). Each TER measurement was normalized
to the TER value of the control epithelia without poly-L-arginine
treatment. The data represent the mean 6 S.E. (* p,0.05, n=4, one-
way ANOVA with Scheffe post-hoc test).
doi:10.1371/journal.pone.0012091.g001
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compared to the time-matched control. Similar results were
obtained when we measured the polarized secretion of IL-8 into
apical (Fig. 3C) or basolateral (Fig. 3D) compartments.
Fig. 4A shows the concentration effect of poly-L-arginine on
IL-6 release in apical and basolateral compartments. Exposure of
the cultured epithelia to 1 to 50 mM poly-L-arginine for 3 hours
stimulated a concentration-dependent increase from 1 to 10 mMi n
IL-6 release into both apical and basolateral compartments, which
gradually decreased. Exposure to various concentrations of poly-L-
arginine for 3 hours induced a significantly higher concentration
of IL-6 release into the apical compartment than into the
basolateral compartment for all concentrations tested. The data
clearly demonstrated polarized secretion of IL-6 into the apical
compartment. Similar results were obtained for IL-8 (Fig. 4B),
showing that there is a concentration-dependent and predomi-
nately apical secretion by the epithelia. To assess if there is
significant diffusion of IL-6 or IL-8 from the apical to the
basolateral compartment, exogenous recombinant IL-6 or IL-8
(4000 pg/ml) were added to the apical compartment, and their
concentrations in the basolateral compartment were measured.
After 6 hours, the IL-6 and IL-8 levels were undetectable (n=3),
indicating that cytokine secretion into the apical compartment
does not significantly contribute to the amount detected on the
other side of the compartment.
Experiments were also performed in which poly-L-arginine
(50 mM) was added to the basolateral compartment for 3 hours
and the IL-6 released into the apical and basolateral compart-
ments was measured. The epithelia secreted a much higher level of
IL-6 into the apical (32506263 pg/ml) than the basolateral
(232646 pg/ml, n=3, p,0.05) compartment, suggesting that
there is polarized secretion of IL-6, regardless of whether the
stimulus was applied from the apical or basolateral side of the
membrane.
To demonstrate whether poly-L-arginine treatment affected
mRNA expression of IL-6 and IL-8, cells were stimulated for 3 or
6 hours with 10 mM poly-L-arginine, and mRNA expression was
measured with qRT-PCR. Increased IL-6 and IL-8 mRNA
Figure 2. Cytokine and chemokine secretion by 16HBE14o- cells stimulated with poly-L-arginine. 16HBE14o- cells were stimulated with
vehicle control (A) or 50 mM poly-L-arginine (B) for 3 hours, and cell supernatants were analyzed using a cytokine antibody array. (C) Summarized data
showing the average optical intensity relative to positive control spots. Results represent the mean 6 S.E. for 6-7 sets of each antibody array
membrane. (c) Internal positive control, (1) IL-8, (2) IL-1a, (3) IL-6, (4) IL-6sR, (5) IL-12p40, (6) RANTES, (7) TNFa. (*, p,0.05, Student’s t-test compared
with untreated control).
doi:10.1371/journal.pone.0012091.g002
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10 mM poly-L-arginine (Fig. 4C and 4D). This cationic polypeptide
had a more potent effect on IL-8 than IL-6 mRNA expression
(.500-fold vs. 50-fold).
Apart from measuring polarized secretion of IL-6 and IL-8 by
16HBE14o- epithelia, poly-L-arginine – induced TNFa and
RANTES secretion into apical and basolateral compartments
were also quantified by ELISA. Under basal conditions, there was
minimal increase in TNFa secretion in both apical and basolateral
compartments while the RANTES level (27.766.6 pg/ml) was
increased in the apical but not basolateral compartment. When
the epithelia were treated with 50 mM poly-L-arginine for 6 hours,
there was a significantly higher concentration of TNFa release into
the apical compartment (16.163.2 pg/ml) than into the basolat-
eral compartment (2.961.0 pg/ml, n=3, p,0.05). Similarly, the
epithelia secreted much higher level of RANTES into apical
(101.7617.9 pg/ml) than the basolateral (24.661.3 pg/ml, n=3,
p,0.05) compartment.
Polarized secretion of IL-6 and IL-8 is regulated by p38
MAPK-, ERK1/2 MAPK-, and NF-kB-dependent pathways
We next examined the effect of various MAPK and NF-kB
inhibitors on poly-L-arginine–induced IL-6 and IL-8 release from
16HBE14o- epithelia because it has been shown that MAPKs
(ERK1/2, p38) and NF-kB are involved in IL-6 [27] and IL-8 [28]
release from epithelial cells. To evaluate the involvement of these
signaling pathways in inducing IL-6 and IL-8 release, selective
pharmacological inhibitors were used. For poly-L-arginine–
induced apical IL-6 secretion, the p38 MAPK inhibitor,
SB203580, suppressed IL-6 production significantly at concentra-
tions of 30 and 50 mM (Fig. 5A). In contrast, the ERK1/2
inhibitor, PD98059, did not show any concentration-dependent
inhibition of IL-6 secretion (Fig. 5B), with the exception of an
effect at 10 mM PD98059. A similar inhibitory profile was also
obtained for apical IL-8 secretion (Fig. 5C and 5D). SB203580 (10
and 50 mM) significantly inhibited IL-8 production, whereas
PD98059 (10–50 mM) produced a similar inhibitory effect. The
NF-kB inhibitor, BAY 11-7085 (10 mM), also significantly blocked
IL-6 (Fig. 5E) and IL-8 (Fig. 5F) production. The effect of these
inhibitors on basolateral IL-6 and IL-8 release was erratic, and no
clear inhibitory effects were observed (data not shown), possibly
due to the small and variable basolateral release of IL-6 and IL-8
compared to the apical release. Taken together, our data suggest
that the apical secretion of IL-6 and IL-8 is mediated through p38
MAPK- and NF-kB-dependent pathways. However, the ERK1/2
pathway may also be involved in IL-8 secretion.
Poly-L-arginine induces p38 and ERK1/2 phosphorylation
and NF-kB translocation
To verify that p38 and ERK1/2 MAPK are implicated in IL-6
and IL-8 release when the cells are challenged with poly-L-
arginine, the ratio of phosphorylated to total p38 and ERK1/2
Figure 3. Time course effect of poly-L-arginine on the release of IL-6 and IL-8 into apical (ap) and basolateral (bl) compartments of
cultured 16HBE14o- cells. 16HBE14o- cells were exposed to 50 mM poly-L-arginine for various periods of time. Cell culture supernatants in both
apical (A and C) and basolateral (B and D) compartments were collected at 1, 2, 3, and 6 hours with time-matched untreated epithelia as control. Each
column represents the mean 6 S.E. (n=4–9). Statistical significance between the apical or basolateral compartment of the same treatment period is
indicated by an asterisk (*p,0.05, Student’s t-test).
doi:10.1371/journal.pone.0012091.g003
Polarized Cytokine Secretion
PLoS ONE | www.plosone.org 5 August 2010 | Volume 5 | Issue 8 | e12091MAPK was measured. Poly-L-arginine activated p38 MAPK in a
time-dependent manner, with a maximum activation after
stimulation for 30 min (Figs. 6A and 6C). Activation of the
ERK1/2 pathway was also confirmed by western blotting, which
showed that phosphorylated ERK1/2 MAPK was elevated in
poly-L-arginine-treated cells (Fig. 6B). Both phosphorylated p42
and p44 were increased after treating the cells with poly-L-arginine
for 10–30 min (Fig. 6D and 6E). IL-1b was used as a positive
control because it activates p38 [29] and ERK1/2 [30] in
16HBE14o- cells (Fig. 6A and 6B).
Immunofluorescent staining demonstrated translocation of NF-
kB from the cytoplasm to the nucleus and confirmed NF-kB
activation upon treatment of the epithelia with poly-L-arginine
(Fig. 7A-F). A summary of these data is shown in Fig. 7G. When
the cells were treated with poly-L-arginine (1 mM) for 30 min, the
nucleus:cytoplasm ratio increased from 0.8660.07 to 1.1560.03,
similar to the increase observed in cells (ratio =1.1560.005)
treated with an inflammatory cocktail consisting of IL-1b, TNFa,
and IFNc [31]. In the presence of BAY 11-7085 (10 mM), NF-kB
translocation was completely abolished (0.8260.05, n=3).
IL-6 and IL-8 do not affect Ca
2+-o r3 9-59-cyclic adenosine
monophosphate (cAMP)-dependent Cl
2 secretion in
16HBE14o- epithelia
Our previous study demonstrated that Cl
2 secretion across the
epithelia is mediated through both Ca
2+- and cAMP-dependent
pathways in 16HBE14o- cells [17]. Because certain cytokines may
alter Ca
2+- or cAMP-dependent Cl
2 secretion [13,14], the effect
of IL-6 and IL-8 on transepithelial Cl
2 secretion and Ca
2+
signaling in 16HBE14o- epithelia was monitored using a
simultaneous measurement technique.
Cells were first incubated with vehicle control (1% bovine serum
albumin, BSA) or 10 ng/ml IL-6 for 24, 48, or 72 hours. The
epithelia were then stimulated with apical application of the Ca
2+-
mobilizing agonist, UTP (100 mM), which activates P2Y4 receptors
expressed in 16HBE14o- cells [17]. Fig. 8A (control) and 8B (IL-6–
treated for 24 hours) show representative recordings of simulta-
neous measurements of ISC and [Ca
2+]i in response to UTP. Apical
application of UTP elicited an increase in ISC, with a concomitant
increase in [Ca
2+]i. Incubation with 10 ng/ml IL-6 did not
significantly affect the time course of the maximal ISC increase
(control: 32.162.6; treated: 33.662.3 mAcm
-2, n=4–6). Similar
results were obtained when epithelia were incubated with IL-6 for
48 (control: 38.362.0; treated: 35.062.3 mAcm
22, n=6, n.s.) or
72 hours (control: 25.865.2; treated: 25.164.2 mAcm
22, n=6,
n.s.). Interestingly, incubation with 10 ng/ml IL-6 caused a small,
albeit significant decrease in the UTP-induced Fura-2 ratio when
the cells were treated with IL-6 for 24 (control: 0.4060.03; treated:
0.3160.03, n=4–6, p,0.05) or 48 hours (control: 0.4160.02;
treated: 0.2860.02 (n=6, p,0.05), but not when cells were
incubated for 72 hours (control: 0.4460.03; treated: 0.3360.06,
n=6, n.s.).
In another series of experiments, a similar approach was used
to examine the effect of IL-6 on cAMP-dependent Cl
2 secretion.
The epithelia were stimulated with the adenylate cyclase
activator, forskolin (10 mM), to elevate the intracellular cAMP
level. Fig. 8C and 8D show representative recordings of
simultaneous measurements of ISC and [Ca
2+]i in response to
Figure 4. Polarized secretion of IL-6 and IL-8 into the apical compartment. 16HBE14o- cells were exposed to 1–50 mM poly-L-arginine, and
cell culture supernatants were collected to measure IL-6 (A) or IL-8 (B) after 3 hours, with untreated epithelia as control. Each column represents the
mean 6 S.E. (n=3–9). Statistical significance between the apical and basolateral compartments of the same treatment concentration is indicated by
an asterisk (* p,0.05, Student’s t-test). mRNA expression of IL-6 (C) and IL-8 (D) was analyzed with qRT-PCR. Epithelia were treated with poly-L-
arginine for 3 or 6 hours. Relative expression of IL-6 and IL-8 was normalized to GAPDH and is shown as fold changes relative to untreated controls.
Each column represents the mean 6 S.E. (n=3).
doi:10.1371/journal.pone.0012091.g004
Polarized Cytokine Secretion
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epithelia (10 ng/ml IL-6 for 24 hours), respectively. Apical
application of forskolin elicited an increase in ISC with no
increase in [Ca
2+]i. Incubation with 10 ng/ml IL-6 had no
significant effect on the maximal ISC response (control: 49.962.7;
treated: 44.564.3 mAcm
22, n=6). Similar results were obtained
when the cells were incubated with IL-6 for a longer period of
time (48 and 72 hours, data not shown).
Using the same protocol, cells were incubated with IL-8 (10 ng/
ml) for 24–72 hours, and then stimulated with either apical
application of UTP or forskolin. Essentially similar effects on ISC
and [Ca
2+]i were observed (data not shown). In general, chronic
exposure of epithelia to IL-6 and IL-8 had no apparent effect on
Ca
2+- or cAMP-dependent Cl
2 secretion across 16HBE14o-
epithelia, despite a slight decrease in nucleotide-evoked [Ca
2+]i
increase.
Discussion
The airway epithelium participates in inflammation in a
number of ways. The surface epithelium itself is responsible for
the synthesis and release of cytokines that cause the selective
recruitment, retention, and accumulation of various inflammatory
cells [3]. Our results confirm that exposing bronchial epithelia to
poly-L-arginine mimics the damage caused by MBP in airway
inflammation. The decrease in TER may be due to an increase in
paracellular permeability as seen in rabbit nasal epithelium [32].
Our antibody array data indicate that challenging the bronchial
epithelia with poly-L-arginine resulted in increased levels of
multiple proinflammatory proteins including IL-6, IL-6sR, IL-8,
TNFa, IL-1a, IL-12p40, and Regulated on Activation Normal T
Cell Expressed and Secreted (RANTES). In this study, we focused
on the polarized secretion of IL-6 and IL-8 because these two
Figure 5. Effect of p38 MAPK, ERK1/2 MAPK, and NF-kB inhibitors on apical IL-6 and IL-8 release by 16HBE14o- cells. Cells were
treated with inhibitor alone or co-incubated with poly-L-arginine (10 mM) in the presence of different concentrations of the inhibitors (mM) for
3 hours. IL-6 (A, B, and E) and IL-8 (C, D, and F) levels were measured with ELISA. Levels of IL-6 and IL-8 were corrected with vehicle control alone and
normalized to 10 mM poly-L-arginine. Each column represents the mean 6 S.E. (n=4). Statistically significant inhibitory effects compared with poly-L-
arginine-treated control are marked with an asterisk (*p,0.05, Student’s t-test).
doi:10.1371/journal.pone.0012091.g005
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importantly, these two cytokines are implicated in the initiation
and perpetuation of local airway inflammatory responses.
To measure the polarized secretion of IL-6 and IL-8
quantitatively, 16HBE14o- monolayers were grown on a perme-
able support so that we could collect both apical and basolateral
media for analysis. The results strongly indicate that there is a
time- and concentration-dependent secretion of IL-6 and IL-8 by
the epithelia into the apical compartment compared to the
basolateral compartment. Polarized secretion of cytokines, includ-
ing IL-6 and IL-8, has been observed in other epithelia.
Preferential apical secretion was shown in lung (Calu-3 and
A549) [33,34], mesothelial [35,36], and female reproductive tract
epithelia [37]. In contrast, other epithelia, such as renal [38,39]
and colonic [40] epithelia show a preferential basolateral secretion,
whereas in retinal pigment epithelium, controversial results were
obtained [41,42]. The direction of polarized secretion therefore
appears to be cell-type-specific and may be related to the
pathophysiology during inflammation and specific innate immune
protection in different tissues.
The polarized secretion of IL-6 and IL-8 (i.e., in an apical-to-
basal gradient) may create a chemotactic gradient and induce
transepithelial neutrophil migration in a manner analogous to the
influx of neutrophils into the airway lumen. Our results strongly
suggest that there is apically directed IL-6 and IL-8 secretion in
polarized 16HBE14o- epithelia, and that the degree of polarized
secretion is always greater in the apical compartment, regardless of
whether the stimulus is applied from the apical or basolateral side
of the membrane. In fact, the majority of eosinophil degranulation
occurs in the lumen of the airway [43]. The exact mechanisms
Figure 6. Poly-L-arginine-induced ERK1/2 MAPK and p38 MAPK activation. 16HBE14o- cells were grown on 6-well plates for 9–10 days until
confluent and were serum starved for 16 hours prior to treatment. Cells were then treated with 10 mM poly-L-arginine or vehicle control for the
indicated periods of time. Total cell lysates were analyzed by SDS-PAGE and immunoblotted with antibodies specific for (A) phospho-p38 MAPK and
p38 MAPK or (B) phospho-ERK1/2 MAPK and ERK1/2 MAPK. Quantification of the western blot is shown in (C–E). The band intensity of the phospho-
MAPK is divided by that of the total MAPK. The phosphoMAPK:total MAPK ratio of the vehicle control was arbitrarily set to 1. IL-1 b (10 ng/ml) was
employed as a positive control, and 0.1% BSA was the vehicle control. Data shown are representative of three independent experiments. (*p,0.05
compared with vehicle control, Student’s t-test).
doi:10.1371/journal.pone.0012091.g006
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stimulated with vehicle control (A and B), 1 mM poly-L-arginine (C and D), or an inflammatory cocktail (TNFa, INF-c, and IL-1b, 10 ng/ml each; E and F)
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finding may account for the attraction of neutrophils into the
airway lumen following airway inflammatory responses. Together
with a decrease in TER and hence barrier function of the
epithelial layer upon poly-L-arginine exposure, the polarized
secretion of potent chemoattractant would greatly facilitate the
migration of immune cells to the lumen of the airway. As a
consequence, the polarized secretion of IL-8 may lead to
neutrophil recruitment and accumulation, as well as enhancement
of IL-8 secretion by neutrophils [44], leading to a positive feedback
cycle and progression of airway inflammation. In addition to the
apical secretion of cytokines, basolaterally secreted cytokines from
epithelia may play another role in supporting the inflammatory
response by attracting immune cells from the underlying cellular
matrix towards the subepithelial space. Moreover, polarized
secretion of TNFa and RANTES by the airway epithelia was
observed, which may further aggravate the inflammation and
recruit more immune cells, respectively.
In airway epithelial cells, the involvement of p38 MAPK activity
in the production of IL-6 [45,46] and IL-8 [28] has been reported
previously. Our experiments demonstrate that the p38 MAPK
inhibitor, SB203580, inhibited poly-L-arginine-induced IL-6 and
for 30 min. The nuclei (A, C, and E) were stained with Hoechst 33342, and NF-kB (B, D, and F) was stained with anti-NF-kB and Alexa Fluor 488 goat
anti-rabbit secondary antibody. (magnification 620) (G) Immunofluorescence of NF-kB in the nuclear region and cytoplasmic region was quantified
using NIH ImageJ software. Nucleus:cytoplasm ratios of NF-kB staining were calculated. Each column represents the mean 6 S.E. (n=3). (*p,0.05
compared with vehicle control, Student’s t-test).
doi:10.1371/journal.pone.0012091.g007
Figure 8. Simultaneous measurement of ISC and [Ca
2+]i in 16HBE14o- epithelia treated with IL-6. Representative recordings of
simultaneous measurements of ISC (upper trace) and [Ca
2+]i (lower trace) in response to apical (ap) application of UTP (A and B) or forskolin (Fors; C
and D) in epithelia treated with 1% BSA (A and C) or 10 ng/ml IL-6 (B and D) for 24 hours. 16HBE14o- cells were initially perfused bilaterally with
normal K-H solution. The apical K-H solution was then changed to a K-H solution with reduced Cl
2 concentration (not shown). Cells were then treated
with apical application of 100 mM amiloride (Ami) 10 min prior to the apical application of 100 mM UTP or 10 mM forskolin (n=6–8).
doi:10.1371/journal.pone.0012091.g008
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confirmed by western blotting. Poly-L-arginine activated p38
MAPK phosphorylation, with a maximal activation after 30 min.
In 16HBE14o- cells, IL-8 release may also be regulated by the
ERK1/2 pathway [47,48]. Although the western blot data confirm
a marked increase in p42- and p44–ERK phosphorylation
following a poly-L-arginine challenge, the selective inhibitor, PD
98059, only produced a modest inhibitory effect on IL-8 secretion.
In contrast, most concentrations of the inhibitor tested did not
significantly suppress IL-6 release. Therefore, it appears that
although IL-8, but not IL-6 release, may be regulated by an
ERK1/2-dependent pathway, the p38 MAPK pathway may be
more important in regulating polarized secretion of IL-6 and IL-8.
Our study therefore provides a mechanistic explanation of how
synthetic polycations induce inflammatory cell migration in the
lungs of animal models [49].
Aside from the basal release of IL-6 and IL-8, poly-L-arginine-
induced cytokine release into the apical compartment was readily
detected 1 hour (IL-8) and 3 hours (IL-6) after stimulation. Our
data indicate that within 30 min, the p38 MAPK, ERK1/2
MAPK, and NF-kB pathways were all activated. This relatively
short period may indicate that the release originates from an
intracellular presynthesized protein. In addition, our results
indicate that the cationic polypeptide stimulates IL-6 and IL-8
in a transcription–dependent manner. Earlier studies have shown
that cationic proteins stimulate IL-8 mRNA expression in
eosinophils [50] and neutrophils [44]. Our results demonstrate a
profound upregulation in both IL-6 and IL-8 gene transcription
after 3 hours of poly-L-arginine stimulation. The effect was more
profound when the cells were treated with poly-L-arginine for
6 hours. The increase in mRNA expression may be due to
activation of NF-kB, which is considered to be a crucial
inflammatory nuclear transcription factor and a central mediator
of inflammatory responses [51]. Previous studies have suggested
that both IL-6 and IL-8 secretion in airway epithelia may be
regulated in an ERK/NF-kB- [48,52] or p38 MAPK/NF-kB-
[28,46] dependent manner. Immunofluorescence data from the
NF-kB activation assay demonstrates translocation from the
cytoplasm to the nucleus after 30 min of poly-L-arginine exposure,
similar to that observed with an inflammatory cocktail. In
addition, blockade of NF-kB activation by its selective inhibitor,
BAY 11-7085, inhibited both IL-6 and IL-8 protein release (,40–
50%), suggesting that the transcription factor NF-kB plays a role
in regulating the expression of these two proinflammatory genes.
However, transcriptional regulation may not be the only
mechanism involved in enhancing cytokine release. In neutrophils,
in addition to a transcriptional effect, the cationic protein may also
regulate post-transcriptional events by prolonging the stability of
mRNA [44]. In fact, p38 MAPK has been implicated in regulating
both the post-transcriptional and translational mechanisms
required for IL-8 protein expression in intestinal epithelia [53].
Our western blot data and the effect of the selective p38 MAPK
inhibitor on IL-6 and IL-8 release strongly suggest that p38
MAPK activation was involved in the secretion process. Because
10 mM BAY 11-7085 did not completely abolish IL-6 and IL-8
secretion but did abolish NF-kB translocation, we cannot exclude
the possibility that part of the effect of poly-L-arginine is
independent of NF-kB activation and may involve other post-
transcriptional mechanisms as seen in intestinal epithelial cells via
activation of p38 MAPK [53]. Taken together, our data indicate
that whereas NF-kB regulates IL-6 and IL-8 mRNA transcription
in airway epithelia, whether the p38 MAPK pathway acts
downstream of, and perhaps parallel to, this process awaits further
investigation.
Recent studies have suggested that certain inflammatory
cytokines affect transepithelial ion transport. In 16HBE14o- cells,
both IL-9 and IL-13 augment UTP-induced Cl
2 secretion via an
increased expression of hCLCA1, a Ca
2+-activated Cl
2 channel
[54]. Therefore, certain cytokines change the balance between
fluid absorption and secretion to favor the hydration of the airway
surface and, consequently, mucus clearance [14]. However, our
study does not support a role for IL-6 or IL-8 in modulating ion
transport activities in 16HBE14o- epithelia. Incubating the
epithelia for up to 72 hours with IL-6 or IL-8 did not affect
Ca
2+- or cAMP-dependent Cl
2 secretion across the epithelia when
stimulated with UTP or forskolin, respectively. Interestingly, a
transient decrease in the UTP-mediated [Ca
2+]i increase was
observed in epithelia treated with IL-6 or IL-8 for 24 to 48 hours.
It has been shown that in human airway epithelia, hyperin-
flammatory responses lead to a larger bradykinin-mediated [Ca
2+]i
increase, which is due to the expanded endoplasmic reticulum/
Ca
2+ store [55]. It appears that IL-6 or IL-8 may not be involved
in mediating the inflammation-induced Ca
2+ store expansion in
airway epithelia.
In summary, the cationic polypeptide, poly-L-arginine, induces
a time- and concentration-dependent polarized IL-6 and IL-8
secretion towards the apical side of bronchial epithelial cells,
effects that are mediated via p38-, ERK1/2-, and NF-kB-
dependent pathways. This phenomenon may contribute to the
pathophysiology of asthmatic inflammation and the development
other inflammatory lung diseases. Further studies on the polarized
expression of these cytokines by bronchial epithelia and the
detailed underlying signaling mechanism(s) may lead to identifi-
cation of important therapeutic targets of airway inflammation.
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